Nanotechnology in hormone replacement therapy: Safe and efficacy of transdermal estriol and estradiol nanoparticles after 5 Years Follow-Up Study

This study aimed to evaluate the safety and efficacy of a novel protocol of transdermal Hormone Replacement Therapy (HRT) based on a nanostructured formulation of Estriol (0.1 %) + Estradiol (0.25 %) restoring serum levels and relieving menopausal symptoms. We evaluated 122 women with mean age of 56...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Gonzaga, Luiz W., Botelho, Marco A., Queiroz, Dinalva, Fechine, Pierre B., Azevedo, Eduardo, Morais, Angélica, Ruela, Ronaldo, Lyra, Aarão, Gomes, Samela, Quintans Júnior, Lucindo José, Freire, Rafael
Formato: Articulo
Lenguaje:Inglés
Publicado: 2012
Materias:
Acceso en línea:http://sedici.unlp.edu.ar/handle/10915/18262
http://www.latamjpharm.org/resumenes/31/3/LAJOP_31_3_1_14.pdf
Aporte de:
id I19-R120-10915-18262
record_format dspace
institution Universidad Nacional de La Plata
institution_str I-19
repository_str R-120
collection SEDICI (UNLP)
language Inglés
topic Farmacia
Nanotecnología
hormone replacement therapy; nanoparticles; raman spectroscopy; menopause; transdermal delivery
Hormonas
Terapia de Reemplazo de Estrógeno
spellingShingle Farmacia
Nanotecnología
hormone replacement therapy; nanoparticles; raman spectroscopy; menopause; transdermal delivery
Hormonas
Terapia de Reemplazo de Estrógeno
Gonzaga, Luiz W.
Botelho, Marco A.
Queiroz, Dinalva
Fechine, Pierre B.
Azevedo, Eduardo
Morais, Angélica
Ruela, Ronaldo
Lyra, Aarão
Gomes, Samela
Quintans Júnior, Lucindo José
Freire, Rafael
Nanotechnology in hormone replacement therapy: Safe and efficacy of transdermal estriol and estradiol nanoparticles after 5 Years Follow-Up Study
topic_facet Farmacia
Nanotecnología
hormone replacement therapy; nanoparticles; raman spectroscopy; menopause; transdermal delivery
Hormonas
Terapia de Reemplazo de Estrógeno
description This study aimed to evaluate the safety and efficacy of a novel protocol of transdermal Hormone Replacement Therapy (HRT) based on a nanostructured formulation of Estriol (0.1 %) + Estradiol (0.25 %) restoring serum levels and relieving menopausal symptoms. We evaluated 122 women with mean age of 56.88 (± 6.27) as part a longitudinal prospective study on post-menopausal women with natural menopause, received in the right forearm a transdermal formulation of (EE) daily for 60 months. Clinical parameters including the degree of satisfaction with symptomatic relief, serum concentrations of estradiol, weight, blood pressure, and bilateral mammography BI-RADS were compared between the baseline and five years after treatment. New evidence regarding this HRT protocol was assessed. The transdermal nanoformulation estradiol improved clinical parameters. Satisfaction with treatment was 92 %. Serum concentrations of estradiol changed significantly after treatment (p < 0.05). Weight and systolic and diastolic blood pressures had no significant differences (p > 0.05) over the years. No vaginal bleeding was observed. Bilateral mammography assessment of the breasts following 60 months of HRT with bioidentical estradiol treatment found normal results in all women. This paper shows for the first time the effectiveness of a nanostructured transdermal formulation enhancer on the delivery of estradiol and estriol measured in vivo using Raman Confocal Spectroscopy. The Nanostructured formulation is safe and effective in reestablishing estradiol serum levels and relieving menopausal symptoms. The nanoformulation may serve as a good choice for hormone replacement therapy to protect against other post-menopausal symptoms.
format Articulo
Articulo
author Gonzaga, Luiz W.
Botelho, Marco A.
Queiroz, Dinalva
Fechine, Pierre B.
Azevedo, Eduardo
Morais, Angélica
Ruela, Ronaldo
Lyra, Aarão
Gomes, Samela
Quintans Júnior, Lucindo José
Freire, Rafael
author_facet Gonzaga, Luiz W.
Botelho, Marco A.
Queiroz, Dinalva
Fechine, Pierre B.
Azevedo, Eduardo
Morais, Angélica
Ruela, Ronaldo
Lyra, Aarão
Gomes, Samela
Quintans Júnior, Lucindo José
Freire, Rafael
author_sort Gonzaga, Luiz W.
title Nanotechnology in hormone replacement therapy: Safe and efficacy of transdermal estriol and estradiol nanoparticles after 5 Years Follow-Up Study
title_short Nanotechnology in hormone replacement therapy: Safe and efficacy of transdermal estriol and estradiol nanoparticles after 5 Years Follow-Up Study
title_full Nanotechnology in hormone replacement therapy: Safe and efficacy of transdermal estriol and estradiol nanoparticles after 5 Years Follow-Up Study
title_fullStr Nanotechnology in hormone replacement therapy: Safe and efficacy of transdermal estriol and estradiol nanoparticles after 5 Years Follow-Up Study
title_full_unstemmed Nanotechnology in hormone replacement therapy: Safe and efficacy of transdermal estriol and estradiol nanoparticles after 5 Years Follow-Up Study
title_sort nanotechnology in hormone replacement therapy: safe and efficacy of transdermal estriol and estradiol nanoparticles after 5 years follow-up study
publishDate 2012
url http://sedici.unlp.edu.ar/handle/10915/18262
http://www.latamjpharm.org/resumenes/31/3/LAJOP_31_3_1_14.pdf
work_keys_str_mv AT gonzagaluizw nanotechnologyinhormonereplacementtherapysafeandefficacyoftransdermalestriolandestradiolnanoparticlesafter5yearsfollowupstudy
AT botelhomarcoa nanotechnologyinhormonereplacementtherapysafeandefficacyoftransdermalestriolandestradiolnanoparticlesafter5yearsfollowupstudy
AT queirozdinalva nanotechnologyinhormonereplacementtherapysafeandefficacyoftransdermalestriolandestradiolnanoparticlesafter5yearsfollowupstudy
AT fechinepierreb nanotechnologyinhormonereplacementtherapysafeandefficacyoftransdermalestriolandestradiolnanoparticlesafter5yearsfollowupstudy
AT azevedoeduardo nanotechnologyinhormonereplacementtherapysafeandefficacyoftransdermalestriolandestradiolnanoparticlesafter5yearsfollowupstudy
AT moraisangelica nanotechnologyinhormonereplacementtherapysafeandefficacyoftransdermalestriolandestradiolnanoparticlesafter5yearsfollowupstudy
AT ruelaronaldo nanotechnologyinhormonereplacementtherapysafeandefficacyoftransdermalestriolandestradiolnanoparticlesafter5yearsfollowupstudy
AT lyraaarao nanotechnologyinhormonereplacementtherapysafeandefficacyoftransdermalestriolandestradiolnanoparticlesafter5yearsfollowupstudy
AT gomessamela nanotechnologyinhormonereplacementtherapysafeandefficacyoftransdermalestriolandestradiolnanoparticlesafter5yearsfollowupstudy
AT quintansjuniorlucindojose nanotechnologyinhormonereplacementtherapysafeandefficacyoftransdermalestriolandestradiolnanoparticlesafter5yearsfollowupstudy
AT freirerafael nanotechnologyinhormonereplacementtherapysafeandefficacyoftransdermalestriolandestradiolnanoparticlesafter5yearsfollowupstudy
bdutipo_str Repositorios
_version_ 1764820464011575296